These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
168 related items for PubMed ID: 17991298
1. Phase I study of magnesium pidolate in combination with hydroxycarbamide for children with sickle cell anaemia. Hankins JS, Wynn LW, Brugnara C, Hillery CA, Li CS, Wang WC. Br J Haematol; 2008 Jan; 140(1):80-5. PubMed ID: 17991298 [Abstract] [Full Text] [Related]
4. The effect of hydroxcarbamide therapy on survival of children with sickle cell disease. Lobo CL, Pinto JF, Nascimento EM, Moura PG, Cardoso GP, Hankins JS. Br J Haematol; 2013 Jun; 161(6):852-60. PubMed ID: 23590693 [Abstract] [Full Text] [Related]
5. Hydroxyurea dose optimisation for children with sickle cell anaemia in sub-Saharan Africa (REACH): extended follow-up of a multicentre, open-label, phase 1/2 trial. Aygun B, Lane A, Smart LR, Santos B, Tshilolo L, Williams TN, Olupot-Olupot P, Stuber SE, Tomlinson G, Latham T, Ware RE, REACH Investigators. Lancet Haematol; 2024 Jun; 11(6):e425-e435. PubMed ID: 38701812 [Abstract] [Full Text] [Related]
9. When should hydroxyurea be used for children with sickle cell disease? Mueller BU. Pediatrics; 2008 Dec 01; 122(6):1365-6. PubMed ID: 19047256 [No Abstract] [Full Text] [Related]
11. Hydroxycarbamide in very young children with sickle-cell anaemia: a multicentre, randomised, controlled trial (BABY HUG). Wang WC, Ware RE, Miller ST, Iyer RV, Casella JF, Minniti CP, Rana S, Thornburg CD, Rogers ZR, Kalpatthi RV, Barredo JC, Brown RC, Sarnaik SA, Howard TH, Wynn LW, Kutlar A, Armstrong FD, Files BA, Goldsmith JC, Waclawiw MA, Huang X, Thompson BW, BABY HUG investigators. Lancet; 2011 May 14; 377(9778):1663-72. PubMed ID: 21571150 [Abstract] [Full Text] [Related]
15. Chromosome damage and repair in children with sickle cell anaemia and long-term hydroxycarbamide exposure. McGann PT, Howard TA, Flanagan JM, Lahti JM, Ware RE. Br J Haematol; 2011 Jul 14; 154(1):134-40. PubMed ID: 21542824 [Abstract] [Full Text] [Related]
16. Optimizing Hydroxyurea use in children with sickle cell disease: low dose regimen is effective. Sharef SW, Al-Hajri M, Beshlawi I, Al-Shahrabally A, Elshinawy M, Zachariah M, Mevada ST, Bashir W, Rawas A, Taqi A, Al-Lamki Z, Wali Y. Eur J Haematol; 2013 Jun 14; 90(6):519-24. PubMed ID: 23489171 [Abstract] [Full Text] [Related]